Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency [Phase 2]
Phase 2 trial investigating docetaxel, carboplatin, and rucaparib camsylate in metastatic castration-resistant prostate cancer with homologo…
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating talazoparib in combination with temozolomide in prostate cancer has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 clinical trial update for Copper-64 PSMA I&T PET imaging in men with newly diagnosed prostate cancer; study status is active not rec…
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer [Phase 3]
Phase 3 multicenter trial evaluating focused ultrasound therapy vs active surveillance in significant low-risk prostate cancer is listed as …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer [NA]
Clinical trial results for androgen deprivation therapy before prostatectomy in intermediate and high-risk prostate cancer have been complet…
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer [Phase 2]
Phase 2 clinical trial results of flibanserin in men undergoing androgen suppression for prostate cancer have been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency [Phase 2]
Phase 2 trial evaluating quality of life improvements in prostate cancer survivors with androgen deficiency.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging [Phase 2]
Phase 2 clinical trial evaluating hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: Project HERO: Health Empowerment & Recovery Outcomes [NA]
Clinical trial results for Project HERO investigating health empowerment and recovery outcomes in cancer patients; study completed and resul…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers [NA]
Clinical trial results evaluating medico-economic aspects of IMRT techniques (Hi Art, RapidArc, VMAT) in prostate, cervix, and anal canal ca…
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer [Phase 2]
Phase 2 trial evaluating phenelzine sulfate for non-metastatic recurrent prostate cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate [Phase 3]
Phase 3 randomized study evaluating MACE in prostate cancer patients treated with relugolix versus leuprolide acetate completed with posted …
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) [Phase 3]
Phase III trial evaluating 177Lu-PSMA-617 plus standard of care versus standard of care alone in metastatic hormone-sensitive prostate cance…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer [Phase 3]
Phase 3 trial assessing adding apalutamide to radiotherapy and LHRH agonist in high-risk hormone-sensitive prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS [Phase 3]
Phase 3 trial evaluating apalutamide (JNJ-56021927) in high-risk prostate cancer patients receiving primary radiation therapy (ATLAS).
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy [Phase 3]
A Phase 3 clinical trial evaluating apalutamide in high-risk localized or locally advanced prostate cancer patients eligible for radical pro…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue [NA]
Pivotal study results for the NanoKnife System using ablation in prostate tissue have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prost…
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer [Phase 1]
Phase 1 trial results of ARV-110 combined with Abiraterone in metastatic prostate cancer were completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. [Phase 3]
Phase 3 trial investigating whether combining Mevrometostat (PF-06821497) with enzalutamide improves outcomes versus enzalutamide alone in A…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating multi-arm, multi-modality therapy for very high risk localized and low-volume metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating external beam radiotherapy and high-dose-rate brachytherapy for unfavorable-intermediate, high, and very high-risk …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer [Phase 2]
Phase 2 study evaluating a multi-drug regimen combining either Abiraterone Acetate or Enzalutamide with Atezolizumab, a GnRH analog, and rad…